Company registration number 10245566 (England and Wales)
WESTGATE HEALTHCARE PROPERTIES LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
WESTGATE HEALTHCARE PROPERTIES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 9
WESTGATE HEALTHCARE PROPERTIES LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
5
2,550,647
2,651,402
Current assets
Debtors
6
597,782
598,063
Cash at bank and in hand
20,589
30,643
618,371
628,706
Creditors: amounts falling due within one year
7
(2,091,775)
(2,073,291)
Net current liabilities
(1,473,404)
(1,444,585)
Total assets less current liabilities
1,077,243
1,206,817
Creditors: amounts falling due after more than one year
8
(1,079,247)
(1,154,034)
Provisions for liabilities
(35,441)
(38,996)
Net (liabilities)/assets
(37,445)
13,787
Capital and reserves
Called up share capital
11
1
1
Revaluation reserve
10
80,223
80,223
Profit and loss reserves
(117,669)
(66,437)
Total equity
(37,445)
13,787
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 25 September 2025 and are signed on its behalf by:
S. C. Patel
Director
Company registration number 10245566 (England and Wales)
WESTGATE HEALTHCARE PROPERTIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information
Westgate Healthcare Properties Limited is a private company limited by shares incorporated in England and Wales. The registered office and business address is at Unit 3 Devonshire Business Park, Chester Road, Borehamwood, Hertfordshire, WD6 1NA.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties at fair value. The principal accounting policies adopted are set out below.
1.2
Going concern
The financial statements have been prepared on a going concern basis notwithstanding the excess of current net liabilities over current net assets. Because of the forbearance of the company's creditors and their willingness to support the company, the directors are confident that the company will be able to continue its activities for the foreseeable future.
1.3
Turnover
Turnover represents the total invoice value, excluding VAT, of rents and service charges receivable from the company's freehold land and buildings and is recognised when the company obtains an unconditional right to consideration in exchange for their performance under any contracts or leases.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Freehold buildings are recognised on the date contracts are exchanged.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold buildings
Nil
Plant and machinery, etc.
15% reducing balance
Freehold property is held in the accounts under the revaluation model. Revaluations will be made with sufficient regularity to ensure that the carrying amount does not differ materially from that which would be determined using fair value at the end of the reporting period.
No depreciation is provided on the company’s freehold buildings. Given the length of life of the buildings and because they are maintained to a high standard, it is the opinion of the directors that the residual values would be sufficiently high to make any depreciation charge immaterial.
WESTGATE HEALTHCARE PROPERTIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
The fair value of the freehold land and buildings has been arrived at on the basis of a valuation carried out at 31 December 2024 by the directors. The valuation was made on an open market basis by reference to mark evidence of transaction prices for similar properties.
The surplus or deficit on book value is transferred to the revaluation reserve, except that a deficit which is in excess of any previously recognised surplus over depreciated cost relating to the same property, or the reversal of such a deficit, is charged (or credited) to the profit and loss account. A deficit which represents a clear consumption of economic benefits is charged to the profit and loss account regardless of any such previous surplus.
On disposal or recognition of a provision for impairment of a revalued fixed asset any related balance remaining in the revaluation reserve is also transferred to the profit and loss account as a movement on reserves.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.6
Cash and cash equivalents
Cash and cash equivalents include cash in hand and deposits held at call with banks.
1.7
Financial instruments
A financial instrument is a contract that gives rise to a financial asset of one entity and a financial liability of another entity. They are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
WESTGATE HEALTHCARE PROPERTIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans and loans from fellow group that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
WESTGATE HEALTHCARE PROPERTIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.10
All borrowing costs, including interest incurred on loans used to finance construction projects, are recognised in the profit and loss over the term of the borrowings.
2
Judgements and key sources of estimation uncertainty
The directors make estimates and assumptions concerning the future. The resulting accounting estimate will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are addressed below.
The company carries its freehold land and property under the revaluation model. The land and buildings have been valued on an open value basis at 31 December 2024 by the directors. The valuations are made on an open market value basis by reference to market evidence of transaction prices for similar properties.
3
Employees
There were no employees during the current year or the prior year.
4
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
14,900
4,246
Adjustments in respect of prior periods
54
Total current tax
14,954
4,246
Deferred tax
Origination and reversal of timing differences
(3,555)
(3,308)
Total tax charge
11,399
938
WESTGATE HEALTHCARE PROPERTIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2024
2,530,000
322,417
2,852,417
Additions
3,000
3,000
Revaluation
(85,000)
(85,000)
At 31 December 2024
2,445,000
325,417
2,770,417
Depreciation and impairment
At 1 January 2024
201,015
201,015
Depreciation charged in the year
18,755
18,755
At 31 December 2024
219,770
219,770
Carrying amount
At 31 December 2024
2,445,000
105,647
2,550,647
At 31 December 2023
2,530,000
121,402
2,651,402
6
Debtors
2024
2023
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
597,782
585,000
Other debtors
13,063
597,782
598,063
7
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
74,467
73,172
Trade creditors
2,701
9,536
Amounts owed to group undertakings
1,974,717
1,899,855
Corporation tax
14,900
4,246
Other taxation and social security
10,143
69,717
Other creditors
14,847
16,765
2,091,775
2,073,291
WESTGATE HEALTHCARE PROPERTIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
8
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans
1,079,247
1,154,034
The company has three loans with Metro Bank PLC.
The first loan amounted to £443,299 at 31 December 2024 and is secured by fixed and floating charges over the company's assets including one of its freehold properties, a cross company guarantee from Westgate Healthcare Group Limited and a personal guarantee from Mr P.S. Patel, one of the directors.
During the year, interest was payable on the loan at a rate of 3% per annum above the Base Rate. Repayment of the loan commenced on 22 January 2017 and it will be repaid by 22 December 2036.
The second loan amounted to £350,467 at 31 December 2024 and is secured by fixed and floating charges over the company's assets including one of its freehold properties, a cross company guarantee from Westgate Healthcare Group Limited and a personal guarantee from Mr P.S. Patel.
During the year, interest was payable on the loan at 3% per annum above the Base Rate. Repayment of the loan commenced on 28 February 2017 and it will be repaid by 31 January 2032.
A third loan amounted to £359,948 at 31 December 2024 and is secured by fixed and floating charges over the company's assets including one of its freehold properties and a personal guarantee from Mr P.S. Patel.
During the year, interest was payable on the loan at 3% per annum above the Base Rate. Repayment of the loan commenced on 5 February 2019 and it will be repaid by 5 January 2038.
Creditors which fall due after five years are as follows:
2024
2023
£
£
Payable by instalments
711,140
806,243
9
Deferred taxation
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:
Liabilities
Liabilities
2024
2023
Balances:
£
£
Accelerated capital allowances
24,662
28,217
Revaluation of tangible fixed assets
10,779
10,779
35,441
38,996
WESTGATE HEALTHCARE PROPERTIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
9
Deferred taxation
(Continued)
- 8 -
2024
Movements in the year:
£
Liability at 1 January 2024
38,996
Credit to profit or loss
(3,555)
Liability at 31 December 2024
35,441
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so.
The expected net reversal of deferred tax assets and liabilities in 2025 cannot be reliably estimated.
There is no expiry date on timing differences.
10
Revaluation reserve
2024
2023
£
£
At the beginning and end of the year
80,223
80,223
11
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
1 Ordinary Share of £1
1
1
1
1
12
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:
The auditor's report was unqualified.
Senior Statutory Auditor:
Stephen Simou FCA
Statutory Auditor:
TC Group
Date of audit report:
30 September 2025
13
Related party transactions
The company has taken advantage of the exemption in FRS 102 Section 33 - Related Party Disclosures, from the requirement to disclose transactions with wholly owned companies within the same group.true
WESTGATE HEALTHCARE PROPERTIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
14
Parent company
The parent company is Westgate Healthcare Group Limited ('WHGL'), a company registered in England and Wales.
Consolidated financial statements are prepared by WHGL, copies of which are available from the company at the registered office.
2024-12-312024-01-01falsefalsefalse30 September 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityA. P. PatelP. S. PatelS. C. PatelS. P. FoxonT. D. Teubner0102455662024-01-012024-12-31102455662024-12-31102455662023-12-3110245566core:LandBuildings2024-12-3110245566core:OtherPropertyPlantEquipment2024-12-3110245566core:LandBuildings2023-12-3110245566core:OtherPropertyPlantEquipment2023-12-3110245566core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3110245566core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3110245566core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3110245566core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3110245566core:CurrentFinancialInstruments2024-12-3110245566core:CurrentFinancialInstruments2023-12-3110245566core:ShareCapital2024-12-3110245566core:ShareCapital2023-12-3110245566core:RevaluationReserve2024-12-3110245566core:RevaluationReserve2023-12-3110245566core:RetainedEarningsAccumulatedLosses2024-12-3110245566core:RetainedEarningsAccumulatedLosses2023-12-3110245566core:ShareCapitalOrdinaryShareClass12024-12-3110245566core:ShareCapitalOrdinaryShareClass12023-12-3110245566bus:Director32024-01-012024-12-3110245566core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3110245566core:FurnitureFittings2024-01-012024-12-3110245566core:UKTax2024-01-012024-12-3110245566core:UKTax2023-01-012023-12-31102455662023-01-012023-12-3110245566core:LandBuildings2023-12-3110245566core:OtherPropertyPlantEquipment2023-12-31102455662023-12-3110245566core:LandBuildings2024-01-012024-12-3110245566core:OtherPropertyPlantEquipment2024-01-012024-12-3110245566core:WithinOneYear2024-12-3110245566core:WithinOneYear2023-12-3110245566core:Non-currentFinancialInstruments2024-12-3110245566core:Non-currentFinancialInstruments2023-12-3110245566bus:OrdinaryShareClass12024-01-012024-12-3110245566bus:OrdinaryShareClass12024-12-3110245566bus:OrdinaryShareClass12023-12-3110245566bus:PrivateLimitedCompanyLtd2024-01-012024-12-3110245566bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110245566bus:FRS1022024-01-012024-12-3110245566bus:Audited2024-01-012024-12-3110245566bus:Director12024-01-012024-12-3110245566bus:Director22024-01-012024-12-3110245566bus:Director42024-01-012024-12-3110245566bus:Director52024-01-012024-12-3110245566bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP